UCB and Biogen’s dapirolizumab pegol paves path for systemic lupus erythematosus treatment GlobalData Nov 13, 2024 With a novel CD40L-targeting mechanism and favourable efficacy outcomes, this therapy has the potential to challenge established…
AbbVie submits applications for Upadacitinib in to US FDA and EMA EP News Bureau Jan 10, 2022 In the trial study, evaluating the efficacy and safety of Upadacitinib in adult patients with nr-axSpA, Upadacitinib met its…
